Paul T Quinlan - Net Worth and Insider Trading

Paul T Quinlan Net Worth

The estimated net worth of Paul T Quinlan is at least $0 dollars as of 2024-04-28. Paul T Quinlan is the General Counsel of CymaBay Therapeutics Inc and owns about 0 shares of CymaBay Therapeutics Inc (CBAY) stock worth over $0. Details can be seen in Paul T Quinlan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Paul T Quinlan has not made any transactions after 2024-01-16 and currently still holds the listed stock(s).

Transaction Summary of Paul T Quinlan

To

Paul T Quinlan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Paul T Quinlan owns 2 companies in total, including CymaBay Therapeutics Inc (CBAY) , and TerraVia Holdings Inc (TVIAQ) .

Click here to see the complete history of Paul T Quinlan’s form 4 insider trades.

Insider Ownership Summary of Paul T Quinlan

Ticker Comapny Transaction Date Type of Owner
CBAY CymaBay Therapeutics Inc 2024-01-16 General Counsel
TVIAQ TerraVia Holdings Inc 2017-03-09 General Counsel

Paul T Quinlan Latest Holdings Summary

Paul T Quinlan currently owns a total of 1 stock. Paul T Quinlan owns 0 shares of CymaBay Therapeutics Inc (CBAY) as of January 16, 2024, with a value of $0.

Latest Holdings of Paul T Quinlan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CBAY CymaBay Therapeutics Inc 2024-01-16 0 32.48 0

Holding Weightings of Paul T Quinlan


Paul T Quinlan Form 4 Trading Tracker

According to the SEC Form 4 filings, Paul T Quinlan has made a total of 9 transactions in CymaBay Therapeutics Inc (CBAY) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in CymaBay Therapeutics Inc is the sale of 5,000 shares on January 16, 2024, which brought Paul T Quinlan around $117,900.

Insider Trading History of Paul T Quinlan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Paul T Quinlan Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Paul T Quinlan Ownership Network

Ownership Network List of Paul T Quinlan

No Data

Ownership Network Relation of Paul T Quinlan


Paul T Quinlan Owned Company Details

What does CymaBay Therapeutics Inc do?

Who are the key executives at CymaBay Therapeutics Inc?

Paul T Quinlan is the General Counsel of CymaBay Therapeutics Inc. Other key executives at CymaBay Therapeutics Inc include Chief Scientific Officer Charles Mcwherter , Vice President & Finance Daniel Menold , and director & Chief Executive Officer Sujal Shah .

CymaBay Therapeutics Inc (CBAY) Insider Trades Summary

Over the past 18 months, Paul T Quinlan made 9 insider transaction in CymaBay Therapeutics Inc (CBAY) with a net sale of 93,000. Other recent insider transactions involving CymaBay Therapeutics Inc (CBAY) include a net sale of 171,559 shares made by Charles Mcwherter , a net sale of 52,442 shares made by Daniel Menold , and a net sale of 19,000 shares made by Janet Dorling .

In summary, during the past 3 months, insiders sold 6,000 shares of CymaBay Therapeutics Inc (CBAY) in total and bought 0 shares, with a net sale of 6,000 shares. During the past 18 months, 601,746 shares of CymaBay Therapeutics Inc (CBAY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 601,746 shares.

CymaBay Therapeutics Inc (CBAY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CymaBay Therapeutics Inc Insider Transactions

No Available Data

Paul T Quinlan Mailing Address

Above is the net worth, insider trading, and ownership report for Paul T Quinlan. You might contact Paul T Quinlan via mailing address: C/o Cymabay Therapeutics, Inc., 7575 Gateway Blvd., Suite 110, Newark Ca 94560.

Discussions on Paul T Quinlan

No discussions yet.